Sara Farshchi Zarabi

1PUBLICATIONS
0CO-AUTHORS
Synchrotrons and accelerators not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 10, 2017
Remissions after third induction chemotherapy for primary non-responders with acute myeloid leukemia (AML) are uncommon and short-lived.

Sara Farshchi Zarabi, Steven Chan, Vikas Gupta

Pageof 1

Frequent Collaborators